Evidence map›Paper›PMID 30213095›Full record

Trial reportNutrients2018

Potassium Citrate Supplementation Decreases the Biochemical Markers of Bone Loss in a Group of Osteopenic Women: The Results of a Randomized, Double-Blind, Placebo-Controlled Pilot Study.

Donatella Granchi, Renata Caudarella, Claudio Ripamonti, Paolo Spinnato, Alberto Bazzocchi, Annamaria Massa, Nicola Baldini

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02731820 (Efficacy of Potassium Citrate in the Treatment of Postmenopausal Osteopenia. A Randomized, Placebo-controlled, Double Blind Investigation.), which is not on this map. Cited by 13 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 4 pooled it
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02731820 nacompletednot on this map

Efficacy of Potassium Citrate in the Treatment of Postmenopausal Osteopenia. A Randomized, Placebo-controlled, Double Blind Investigation.

TypeinterventionalSponsorIstituto Ortopedico RizzoliRan2015 to 2017Enrolled40ConditionsOsteopenia, Bone Disease, MetabolicArmsPotassium citrate, Placebo, Vitamin D3, Calcium carbonate
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 4 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Citrate-based dietary alkali supplements available in Germany: an overview.Journal of pharmaceutical health care and sciences · 2024
    Article
  6. Nutraceuticals in osteoporosis prevention.Frontiers in nutrition · 2024
    Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Donatella GranchiLaboratory for Orthopedic Pathophysiology and Regenerative Medicine, IRCCS Istituto Ortopedico Rizzoli, via di Barbiano 1/10, 40136 Bologna, Italy. donatella.granchi@ior.it.
Renata CaudarellaVillalba Hospital, GVM Care and Research, Via di Roncrio, 25, 40136 Bologna, Italy. renata.caudarella@alice.it.
Claudio RipamontiOsteoporosis and Metabolic Bone Disease Unit, IRCCS Istituto Ortopedico Rizzoli, via Pupilli 1, 40136 Bologna, Italy. claudio.ripamonti@ior.it.
Paolo SpinnatoDiagnostic and Interventional Radiology, IRCCS Istituto Ortopedico Rizzoli, via Pupilli 1, 40136 Bologna, Italy. paolo.spinnato@ior.it.
Alberto BazzocchiDiagnostic and Interventional Radiology, IRCCS Istituto Ortopedico Rizzoli, via Pupilli 1, 40136 Bologna, Italy. alberto.bazzocchi@ior.it.
Annamaria MassaLaboratory for Orthopedic Pathophysiology and Regenerative Medicine, IRCCS Istituto Ortopedico Rizzoli, via di Barbiano 1/10, 40136 Bologna, Italy. annamaria.massa88@gmail.com.
Nicola BaldiniLaboratory for Orthopedic Pathophysiology and Regenerative Medicine, IRCCS Istituto Ortopedico Rizzoli, via di Barbiano 1/10, 40136 Bologna, Italy. nicola.baldini@ior.it.
Istituto Ortopedico Rizzoli · ITVilla Torri Hospital · IT

Funding

Fondazione del Monte di Bologna e Ravenna Women's and Children's Health - Grant 2015 to N.B.Italian Ministry of Health Ricerca Corrente 2018
6 · The paper itself

Abstract

The relationship involving acid-base imbalance, mineral metabolism and bone health status has previously been reported but the efficacy of the alkalizing supplementation in targeting acid overload and preventing bone loss has not yet been fully elucidated. In this randomized, double-blind, placebo-controlled study, the hypothesis that potassium citrate (K citrate) modifies bone turnover in women with postmenopausal osteopenia was tested. Three hundred and ten women were screened; 40 women met the inclusion criteria and were randomly assigned to the treatment or the placebo group. They were treated with K citrate (30 mEq day

Indexed as

Dietary SupplementsAcid-Base EquilibriumAgedBiomarkersBone Density Conservation AgentsBone Diseases, MetabolicBone RemodelingDouble-Blind MethodFemaleHumansItalyMiddle AgedPilot ProjectsPotassium CitrateProspective StudiesTime FactorsBiomarkersBone Density Conservation AgentsPotassium Citrateacid-basebone remodelingbone turnover markersosteopeniapotassium citrateurolithiasis

Identifiers

PMID30213095
PMCPMC6164684
OpenAlexW2891615534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.